Arcturus Therapeutics Holdings Inc (ARCT) — Cash Flow Reinvestment Rate
Arcturus Therapeutics Holdings Inc (ARCT) has a Cash Flow Reinvestment Rate of 0.01x as of June 2023, reinvesting $708.00K (capex $354.00K plus investments $-354.00K) from operating cash flow of $50.81 Million. Check Arcturus Therapeutics Holdings Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Arcturus Therapeutics Holdings Inc Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for Arcturus Therapeutics Holdings Inc across 1 annual periods. Explore investment intensity of Arcturus Therapeutics Holdings Inc to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Arcturus Therapeutics Holdings Inc (2022–2022)
Year-by-year capital reinvestment analysis for Arcturus Therapeutics Holdings Inc. For live market cap and broader valuation context, see ARCT market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.48x | $15.45 Million | $31.99 Million | $7.73 Million | — |